31![Rapporteur’s Public Assessment Report for paediatric studies submitted in accordance with Article 46 of Regulation (EC) No1901/2006, as amended Seretide Evohaler/Viani Evohaler, Seretide Diskus/Viani Rapporteur’s Public Assessment Report for paediatric studies submitted in accordance with Article 46 of Regulation (EC) No1901/2006, as amended Seretide Evohaler/Viani Evohaler, Seretide Diskus/Viani](https://www.pdfsearch.io/img/061dc0e7dccc6ed49d0dcecc4e50c60c.jpg) | Add to Reading ListSource URL: www.hma.euLanguage: English - Date: 2011-01-05 07:16:25
|
---|
32![Public Assessment Report for paediatric studies submitted in accordance with Article 46 of Regulation (EC) No1901/2006, as amended Seretide Public Assessment Report for paediatric studies submitted in accordance with Article 46 of Regulation (EC) No1901/2006, as amended Seretide](https://www.pdfsearch.io/img/f1828656451de093f60a1c30571b786d.jpg) | Add to Reading ListSource URL: www.hma.euLanguage: English - Date: 2013-06-20 11:23:14
|
---|
33![GLAXOSMITHKLINE Sponsor Briefing Information ADVAIR DISKUS® (fluticasone propionate/salmeterol inhalation powder[removed]mcg, [removed]mcg and[removed]mcg GLAXOSMITHKLINE Sponsor Briefing Information ADVAIR DISKUS® (fluticasone propionate/salmeterol inhalation powder[removed]mcg, [removed]mcg and[removed]mcg](https://www.pdfsearch.io/img/63b7e1b0d1cd2de506c34838d0b9cd15.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2008-12-05 08:30:11
|
---|
34![DOCUMENT INFORMATION PAGE DOCUMENT INFORMATION PAGE](https://www.pdfsearch.io/img/e018bed1fabb6552877c511f3ea05899.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 16:05:30
|
---|
35![](https://www.pdfsearch.io/img/b7ffd5f8bd267715aa5bb4d97caf1526.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2011-01-05 14:23:33
|
---|
36![1 2 3 MEDICATION GUIDE ADVAIR HFA [ad′ vair[removed]Inhalation Aerosol 1 2 3 MEDICATION GUIDE ADVAIR HFA [ad′ vair[removed]Inhalation Aerosol](https://www.pdfsearch.io/img/863bb86b0f22b250a1feb0ef5dec5084.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2011-01-05 14:23:33
|
---|
37![DIVISION OF BIOEQUIVALENCE REVIEW DIVISION OF BIOEQUIVALENCE REVIEW](https://www.pdfsearch.io/img/2765ec5928eed29b4ff355d5deaac327.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
38![DOCUMENT INFORMATION PAGE DOCUMENT INFORMATION PAGE](https://www.pdfsearch.io/img/bac457b717152b2373acf7214770274c.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 16:06:05
|
---|
39![IMPORTANT REVISIONS TO PRESCRIBING INFORMATION FOR SEREVENT® (salmeterol xinafoate) AND ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder) GlaxoSmithKline PO Box 13398 IMPORTANT REVISIONS TO PRESCRIBING INFORMATION FOR SEREVENT® (salmeterol xinafoate) AND ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder) GlaxoSmithKline PO Box 13398](https://www.pdfsearch.io/img/69bbab10987600512c1888b27ff62e6e.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
40![](https://www.pdfsearch.io/img/bee826213bead239a4d74ae3bc59c81d.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|